Kim De Keersmaecker/ LinkedIn
Jun 13, 2026, 17:11
Kim De Keersmaecker: Advancing Hematology Through Shared Expertise at EHA 2026
Kim De Keersmaecker, Full Professor in Oncology at KU Leuven, shared a post on LinkedIn:
“Fantastic to attend the 2026 European Hematology meeting (EHA2026) in Stockholm with such a nice delegation from our Leuven Kankerinstituut focus group Hematology!
Like every year, it is really stimulating to have hematology clinicians and researchers united to share the most fascinating novel developments in our field.”
Stay updated with Hemostasis Today.
-
Jun 13, 2026, 17:03Nour Al-Mozain: The Evolving Role of Apheresis Across Clinical Practice
-
Jun 13, 2026, 16:45Sarah Hendry: A Big Day for Gene Therapy Research at EHA 2026
-
Jun 13, 2026, 16:43Akshat Jain: Bridging Innovation and Access in Hematology at EHGCON 2026
-
Jun 13, 2026, 16:21Alvaro Herrera Pérez: Connecting Science and Care at EHA 2026
-
Jun 13, 2026, 16:07Isabelle Mahé: Connecting Expertise in Antithrombotic Care at ISTH 2026
-
Jun 13, 2026, 16:02Tarun Aurora։ Towards Better Risk Stratification in Sickle Cell Disease
-
Jun 13, 2026, 15:59Irene Cuppari: Whole Blood and Component Therapy in Traumatic Hemorrhage
-
Jun 13, 2026, 15:39Ritu Verma: Recognizing Deep Vein Thrombosis Before Complications Arise
-
Jun 13, 2026, 15:09Akshat Jain: Does Mitapivat Translate to Clinical Benefit in SCD?